share_log

Anebulo Pharmaceuticals Q2 EPS $(0.11) Misses $(0.10) Estimate

Anebulo Pharmaceuticals Q2 EPS $(0.11) Misses $(0.10) Estimate

Anebulo Pharmicals第二季度每股收益美元(0.11)未達到預期(0.10)
Moomoo 24/7 ·  02/13 16:43

Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.10) by 10 percent. This is a 26.67 percent increase over losses of $(0.15) per share from the same period last year.

Anebulo Pharmicals(納斯達克股票代碼:ANEB)公佈的季度虧損爲每股0.11美元,比分析師普遍預期的0.10美元(0.10美元)低10%。這比去年同期每股虧損0.15美元(0.15美元)增長了26.67%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論